In conclusion, we demonstrated that DR6 stimulates AKT/NF-κB pathway to promote the malignant features of CRC cells, including the enhancement of cell proliferation, migration, invasion, and cell stemness. This evidence concerns the gene AKT1 and colorectal carcinoma.